Equities Research Analysts’ price target changes for Wednesday, March 18th:
Arthur J. Gallagher & Co. (NYSE:AJG) had its price target trimmed by Truist Financial Corporation from $271.00 to $235.00. Truist Financial Corporation currently has a hold rating on the stock.
Andersen Group (NYSE:ANDG) had its price target raised by Morgan Stanley from $22.00 to $24.00. They currently have an equal weight rating on the stock.
Andersen Group (NYSE:ANDG) had its target price raised by Robert W. Baird from $40.00 to $42.00. They currently have an outperform rating on the stock.
Alto Neuroscience (NYSE:ANRO) had its price target raised by Robert W. Baird from $22.00 to $41.00. The firm currently has an outperform rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price reduced by Cantor Fitzgerald from $35.00 to $31.00. They currently have an overweight rating on the stock.
Academy Sports and Outdoors (NASDAQ:ASO) had its target price trimmed by Wells Fargo & Company from $57.00 to $52.00. They currently have an equal weight rating on the stock.
Academy Sports and Outdoors (NASDAQ:ASO) had its target price lowered by UBS Group AG from $60.00 to $56.00. The firm currently has a neutral rating on the stock.
Academy Sports and Outdoors (NASDAQ:ASO) had its price target trimmed by Barclays PLC from $59.00 to $49.00. The firm currently has an equal weight rating on the stock.
Academy Sports and Outdoors (NASDAQ:ASO) had its target price increased by JPMorgan Chase & Co. from $56.00 to $60.00. They currently have a neutral rating on the stock.
Bicycle Therapeutics (NASDAQ:BCYC) had its target price reduced by Oppenheimer Holdings, Inc. from $44.00 to $36.00. The firm currently has an outperform rating on the stock.
Bicycle Therapeutics (NASDAQ:BCYC) had its price target trimmed by Needham & Company LLC from $24.00 to $15.00. The firm currently has a buy rating on the stock.
Bicycle Therapeutics (NASDAQ:BCYC) had its price target lowered by Royal Bank Of Canada from $11.00 to $7.00. The firm currently has a sector perform rating on the stock.
Bicycle Therapeutics (NASDAQ:BCYC) had its price target lowered by Citizens Jmp from $12.00 to $8.00. They currently have a market outperform rating on the stock.
Bakkt (NYSE:BKKT) had its price target lowered by Benchmark Co. from $40.00 to $22.00. They currently have a buy rating on the stock.
TopBuild (NYSE:BLD) had its price target reduced by DA Davidson from $485.00 to $465.00. DA Davidson currently has a buy rating on the stock.
Bullish (NYSE:BLSH) had its price target trimmed by Citigroup Inc. from $67.00 to $65.00. Citigroup Inc. currently has a buy rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its price target cut by Morgan Stanley from $25.50 to $23.00. Morgan Stanley currently has an overweight rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its price target lowered by JPMorgan Chase & Co. from $29.00 to $26.00. The firm currently has an overweight rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its target price lowered by Royal Bank Of Canada from $26.00 to $25.00. The firm currently has an outperform rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its target price cut by DA Davidson from $26.00 to $24.00. DA Davidson currently has a buy rating on the stock.
Bob’s Discount Furniture (NYSE:BOBS) had its price target lowered by Robert W. Baird from $22.00 to $16.00. They currently have a neutral rating on the stock.
Boston Scientific (NYSE:BSX) had its target price lowered by Truist Financial Corporation from $95.00 to $92.00. The firm currently has a buy rating on the stock.
BTGO (NYSE:BTGO) had its target price reduced by Citigroup Inc. from $18.00 to $17.00. The firm currently has a buy rating on the stock.
BrightSpring Health Services (NASDAQ:BTSG) had its price target boosted by Mizuho from $50.00 to $52.00. The firm currently has an outperform rating on the stock.
BrightSpring Health Services (NASDAQ:BTSG) had its price target raised by UBS Group AG from $53.00 to $55.00. UBS Group AG currently has a buy rating on the stock.
Cal-Maine Foods (NASDAQ:CALM) had its target price boosted by Stephens from $85.00 to $90.00. Stephens currently has an equal weight rating on the stock.
Perspective Therapeutics (NYSEAMERICAN:CATX) had its target price increased by UBS Group AG from $7.00 to $8.00. They currently have a buy rating on the stock.
Perspective Therapeutics (NYSEAMERICAN:CATX) had its price target boosted by B. Riley Financial, Inc. from $11.00 to $13.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Cogent Communications (NASDAQ:CCOI) had its price target reduced by Royal Bank Of Canada from $23.00 to $22.00. They currently have a sector perform rating on the stock.
Celanese (NYSE:CE) had its target price raised by UBS Group AG from $56.00 to $58.00. They currently have a neutral rating on the stock.
CF Industries (NYSE:CF) had its target price boosted by BMO Capital Markets from $115.00 to $140.00. BMO Capital Markets currently has an outperform rating on the stock.
CF Industries (NYSE:CF) had its price target raised by Bank of America Corporation from $86.00 to $103.00. The firm currently has an underperform rating on the stock.
Clean Harbors (NYSE:CLH) had its target price increased by Wells Fargo & Company from $291.00 to $309.00. The firm currently has an equal weight rating on the stock.
ClearPoint Neuro (NASDAQ:CLPT) had its target price boosted by B. Riley Financial, Inc. from $18.00 to $20.00. They currently have a buy rating on the stock.
Copa (NYSE:CPA) had its price target reduced by Bank of America Corporation from $212.00 to $171.00. Bank of America Corporation currently has a buy rating on the stock.
California Resources (NYSE:CRC) had its price target boosted by Citigroup Inc. from $51.00 to $67.00. They currently have a neutral rating on the stock.
CervoMed (NASDAQ:CRVO) had its price target reduced by Roth Mkm from $19.00 to $11.00. They currently have a buy rating on the stock.
CervoMed (NASDAQ:CRVO) had its price target boosted by Chardan Capital from $15.00 to $21.00. Chardan Capital currently has a buy rating on the stock.
CytomX Therapeutics (NASDAQ:CTMX) had its target price boosted by Guggenheim from $10.00 to $15.00. The firm currently has a buy rating on the stock.
Dakota Gold (NYSE:DC) had its price target increased by HC Wainwright from $9.75 to $10.50. The firm currently has a buy rating on the stock.
Walt Disney (NYSE:DIS) had its price target trimmed by Guggenheim from $140.00 to $115.00. Guggenheim currently has a buy rating on the stock.
Digital Realty Trust (NYSE:DLR) had its price target increased by Barclays PLC from $164.00 to $182.00. Barclays PLC currently has an equal weight rating on the stock.
DigitalOcean (NYSE:DOCN) had its target price raised by Oppenheimer Holdings, Inc. from $85.00 to $100.00. The firm currently has an outperform rating on the stock.
Docusign (NASDAQ:DOCU) had its price target cut by Piper Sandler from $75.00 to $52.00. They currently have a neutral rating on the stock.
Docusign (NASDAQ:DOCU) had its target price cut by Royal Bank Of Canada from $70.00 to $55.00. Royal Bank Of Canada currently has a sector perform rating on the stock.
Docusign (NASDAQ:DOCU) had its price target cut by Morgan Stanley from $90.00 to $69.00. The firm currently has an equal weight rating on the stock.
Docusign (NASDAQ:DOCU) had its price target trimmed by JPMorgan Chase & Co. from $78.00 to $65.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Docusign (NASDAQ:DOCU) had its price target lowered by Wells Fargo & Company from $75.00 to $60.00. The firm currently has an equal weight rating on the stock.
Docusign (NASDAQ:DOCU) had its target price trimmed by Robert W. Baird from $75.00 to $55.00. The firm currently has a neutral rating on the stock.
Docusign (NASDAQ:DOCU) had its target price reduced by Citizens Jmp from $124.00 to $86.00. Citizens Jmp currently has a market outperform rating on the stock.
Docusign (NASDAQ:DOCU) had its price target trimmed by UBS Group AG from $75.00 to $54.00. The firm currently has a neutral rating on the stock.
Ecolab (NYSE:ECL) had its price target reduced by Wells Fargo & Company from $310.00 to $285.00. The firm currently has an equal weight rating on the stock.
Edison International (NYSE:EIX) had its price target boosted by JPMorgan Chase & Co. from $66.00 to $74.00. They currently have a neutral rating on the stock.
Enterprise Products Partners (NYSE:EPD) had its target price boosted by Morgan Stanley from $34.00 to $38.00. The firm currently has an underweight rating on the stock.
Equinix (NASDAQ:EQIX) had its price target raised by Barclays PLC from $870.00 to $1,020.00. Barclays PLC currently has an equal weight rating on the stock.
Erasca (NASDAQ:ERAS) had its price target raised by JPMorgan Chase & Co. from $24.00 to $25.00. The firm currently has an overweight rating on the stock.
Entergy (NYSE:ETR) had its target price boosted by Citigroup Inc. from $106.00 to $116.00. The firm currently has a neutral rating on the stock.
EVE (NYSE:EVEX) had its target price cut by Cantor Fitzgerald from $7.00 to $6.00. The firm currently has an overweight rating on the stock.
Evommune (NYSE:EVMN) had its target price cut by HC Wainwright from $65.00 to $50.00. The firm currently has a buy rating on the stock.
FactSet Research Systems (NYSE:FDS) had its price target reduced by Royal Bank Of Canada from $320.00 to $243.00. They currently have a sector perform rating on the stock.
Fair Isaac (NYSE:FICO) had its target price reduced by Wells Fargo & Company from $2,500.00 to $2,300.00. The firm currently has an overweight rating on the stock.
Fold (NASDAQ:FLD) had its price target reduced by Cantor Fitzgerald from $4.50 to $2.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Fold (NASDAQ:FLD) had its price target reduced by HC Wainwright from $7.00 to $3.00. The firm currently has a buy rating on the stock.
Fortive (NYSE:FTV) had its price target boosted by Morgan Stanley from $53.00 to $58.00. Morgan Stanley currently has an equal weight rating on the stock.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its price target reduced by Guggenheim from $34.00 to $30.00. Guggenheim currently has a buy rating on the stock.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its price target lowered by Wells Fargo & Company from $30.00 to $29.00. Wells Fargo & Company currently has an overweight rating on the stock.
Galaxy Digital (NASDAQ:GLXY) had its target price increased by Citigroup Inc. from $25.00 to $28.00. They currently have a neutral rating on the stock.
Warrior Met Coal (NYSE:HCC) had its target price boosted by Citigroup Inc. from $80.00 to $100.00. Citigroup Inc. currently has a buy rating on the stock.
Hf Foods Group (NASDAQ:HFFG) had its target price trimmed by Roth Mkm from $7.00 to $6.00. They currently have a buy rating on the stock.
HealthEquity (NASDAQ:HQY) had its price target reduced by JPMorgan Chase & Co. from $129.00 to $123.00. The firm currently has an overweight rating on the stock.
HealthEquity (NASDAQ:HQY) had its price target cut by Barrington Research from $125.00 to $110.00. The firm currently has an outperform rating on the stock.
HealthEquity (NASDAQ:HQY) had its price target cut by Royal Bank Of Canada from $110.00 to $100.00. Royal Bank Of Canada currently has an outperform rating on the stock.
International Business Machines (NYSE:IBM) had its price target cut by JPMorgan Chase & Co. from $317.00 to $283.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Installed Building Products (NYSE:IBP) had its price target raised by DA Davidson from $252.00 to $270.00. They currently have a neutral rating on the stock.
LandBridge (NYSE:LB) had its price target raised by Wells Fargo & Company from $90.00 to $92.00. They currently have an overweight rating on the stock.
Lennar (NYSE:LEN) had its price target reduced by Keefe, Bruyette & Woods from $115.00 to $105.00. They currently have a market perform rating on the stock.
Lumentum (NASDAQ:LITE) had its target price raised by Morgan Stanley to $595.00. The firm currently has an equal weight rating on the stock.
lululemon athletica (NASDAQ:LULU) had its target price lowered by JPMorgan Chase & Co. from $209.00 to $196.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
lululemon athletica (NASDAQ:LULU) had its target price cut by Truist Financial Corporation from $200.00 to $170.00. Truist Financial Corporation currently has a hold rating on the stock.
lululemon athletica (NASDAQ:LULU) had its target price reduced by BTIG Research from $250.00 to $225.00. BTIG Research currently has a buy rating on the stock.
lululemon athletica (NASDAQ:LULU) had its target price cut by Telsey Advisory Group from $215.00 to $175.00. The firm currently has a market perform rating on the stock.
lululemon athletica (NASDAQ:LULU) had its price target lowered by Wells Fargo & Company from $175.00 to $150.00. Wells Fargo & Company currently has an equal weight rating on the stock.
lululemon athletica (NASDAQ:LULU) had its price target reduced by Robert W. Baird from $210.00 to $190.00. The firm currently has a neutral rating on the stock.
lululemon athletica (NASDAQ:LULU) had its price target cut by UBS Group AG from $189.00 to $176.00. They currently have a neutral rating on the stock.
lululemon athletica (NASDAQ:LULU) had its price target lowered by Barclays PLC from $203.00 to $161.00. Barclays PLC currently has an equal weight rating on the stock.
Methanex (NASDAQ:MEOH) (TSE:MX) had its price target boosted by BMO Capital Markets from $65.00 to $70.00. The firm currently has an outperform rating on the stock.
Meta Platforms (NASDAQ:META) had its target price increased by Tigress Financial from $935.00 to $945.00. The firm currently has a strong-buy rating on the stock.
Micron Technology (NASDAQ:MU) had its price target boosted by Sanford C. Bernstein from $330.00 to $510.00. Sanford C. Bernstein currently has an outperform rating on the stock.
McEwen (NYSE:MUX) (TSE:MUX) had its price target increased by HC Wainwright from $21.50 to $29.50. The firm currently has a buy rating on the stock.
McEwen (NYSE:MUX) (TSE:MUX) had its price target boosted by Roth Mkm from $30.00 to $35.00. Roth Mkm currently has a buy rating on the stock.
Nutrien (NYSE:NTR) had its target price raised by BMO Capital Markets from $85.00 to $90.00. The firm currently has an outperform rating on the stock.
Nutrien (NYSE:NTR) had its price target raised by Bank of America Corporation from $75.00 to $81.00. They currently have a neutral rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price raised by Truist Financial Corporation from $283.00 to $287.00. The firm currently has a buy rating on the stock.
Oklo (NYSE:OKLO) had its target price lowered by B. Riley Financial, Inc. from $129.00 to $92.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
Oklo (NYSE:OKLO) had its price target lowered by Citigroup Inc. from $95.00 to $73.50. The firm currently has a neutral rating on the stock.
Oklo (NYSE:OKLO) had its price target cut by Needham & Company LLC from $135.00 to $73.00. Needham & Company LLC currently has a buy rating on the stock.
Oklo (NYSE:OKLO) had its price target reduced by Canaccord Genuity Group Inc. from $175.00 to $125.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target reduced by The Goldman Sachs Group, Inc. from $38.00 to $27.00. The firm currently has a buy rating on the stock.
Olema Pharmaceuticals (NASDAQ:OLMA) had its price target raised by JPMorgan Chase & Co. from $55.00 to $58.00. The firm currently has an overweight rating on the stock.
Plains All American Pipeline (NASDAQ:PAA) had its price target increased by Morgan Stanley from $21.00 to $23.00. Morgan Stanley currently has an equal weight rating on the stock.
Plains GP (NYSE:PAGP) had its price target boosted by Morgan Stanley from $22.00 to $24.00. The firm currently has an equal weight rating on the stock.
Pacific Gas & Electric (NYSE:PCG) had its target price boosted by JPMorgan Chase & Co. from $21.00 to $24.00. They currently have an overweight rating on the stock.
Palantir Technologies (NASDAQ:PLTR) had its target price boosted by UBS Group AG from $180.00 to $200.00. UBS Group AG currently has a buy rating on the stock.
Perpetua Resources (NASDAQ:PPTA) had its price target increased by B. Riley Financial, Inc. from $30.00 to $40.00. B. Riley Financial, Inc. currently has a buy rating on the stock.
PTC (NASDAQ:PTC) had its target price lowered by Rosenblatt Securities from $200.00 to $190.00. They currently have a buy rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its price target raised by Oppenheimer Holdings, Inc. from $80.00 to $85.00. The firm currently has an outperform rating on the stock.
Republic Services (NYSE:RSG) had its price target increased by Wells Fargo & Company from $238.00 to $252.00. The firm currently has an overweight rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its target price trimmed by HC Wainwright from $110.00 to $100.00. They currently have a buy rating on the stock.
Soleno Therapeutics (NASDAQ:SLNO) had its price target cut by Oppenheimer Holdings, Inc. from $110.00 to $80.00. They currently have an outperform rating on the stock.
NuScale Power (NYSE:SMR) had its price target cut by UBS Group AG from $20.00 to $13.00. UBS Group AG currently has a neutral rating on the stock.
Sempra Energy (NYSE:SRE) had its price target boosted by JPMorgan Chase & Co. from $98.00 to $106.00. They currently have an overweight rating on the stock.
Steel Dynamics (NASDAQ:STLD) had its target price trimmed by JPMorgan Chase & Co. from $194.00 to $192.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Steel Dynamics (NASDAQ:STLD) had its target price cut by Wells Fargo & Company from $210.00 to $196.00. The firm currently has an overweight rating on the stock.
Sunrise Realty Trust (NASDAQ:SUNS) had its target price lowered by Keefe, Bruyette & Woods from $9.50 to $8.75. They currently have a market perform rating on the stock.
Tencent Music Entertainment Group (NYSE:TME) had its target price trimmed by Mizuho from $28.00 to $23.00. They currently have an outperform rating on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its price target raised by Needham & Company LLC from $22.00 to $24.00. Needham & Company LLC currently has a buy rating on the stock.
Trevi Therapeutics (NASDAQ:TRVI) had its price target reduced by Morgan Stanley from $19.00 to $18.00. They currently have an overweight rating on the stock.
Viavi Solutions (NASDAQ:VIAV) had its price target boosted by Rosenblatt Securities from $27.00 to $42.00. Rosenblatt Securities currently has a buy rating on the stock.
Westlake (NYSE:WLK) had its price target raised by UBS Group AG from $129.00 to $139.00. They currently have a buy rating on the stock.
Waste Management (NYSE:WM) had its price target boosted by Wells Fargo & Company from $250.00 to $273.00. Wells Fargo & Company currently has an overweight rating on the stock.
Zillow Group (NASDAQ:ZG) had its target price lowered by Robert W. Baird from $67.00 to $55.00. They currently have a neutral rating on the stock.
Zai Lab (NASDAQ:ZLAB) had its price target lowered by JPMorgan Chase & Co. from $39.00 to $32.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Receive News & Ratings for Arthur J Gallagher & Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arthur J Gallagher & Co and related companies with MarketBeat.com's FREE daily email newsletter.
